Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
Common treatments for benign prostatic hyperplasia (BPH), like Proscar (finasteride) or Avodart (dutasteride), are suggested to be linked to erectile dysfunction and other sexual problems in a number a studies. ... Read more
Researchers report that the presence of a parasite called Trichomonas vaginalis in the prostate tissue may be associated with the development of benign prostatic hyperplasia (BPH), but more studies are necessary ... Read more
A new report published in the journal Translational Andrology and Urology explored previously published data to help clarify the impact of certain treatments for lower urinary tract symptoms (LUTS) from benign ... Read more
Researchers recently reported that men with a common form of hair loss known as androgenetic alopecia (AGA) were also more likely to develop benign prostatic hyperplasia (BPH) and metabolic syndrome. Now, ... Read more
The risk of undergoing benign prostatic hyperplasia (BPH)-related prostate surgery is lower among men using dutasteride compared to those using finasteride, according to a study published in the BMC Urology journal. This ... Read more
Men with androgenetic alopecia (AGA), the most common male form of hair loss and baldness, have a greater probability of developing benign prostatic hyperplasia (BPH) and metabolic syndrome, a study ... Read more